Cormorant Asset Management LP 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:03 pm Sale |
2024-09-30 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 0 0.000% |
-1,700,000 (Position Closed) |
Filing |
| 2024-04-15 6:10 pm Sale |
2024-04-03 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 1,700,000 5.810% |
-2,504,364 (-59.57%) |
Filing |
| 2023-04-24 5:26 pm Purchase |
2023-04-20 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 4,204,364 14.420% |
1,918,183 (+83.90%) |
Filing |
| 2023-02-14 3:13 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 2,286,181 8.660% |
33,553 (+1.49%) |
Filing |
| 2021-08-13 4:01 pm Purchase |
2021-08-03 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 2,252,628 8.830% |
2,252,628 (New Position) |
Filing |